Zhang Haisheng is the founder of Signet Therapeutics. Signet Therapeutics has raised $31M in total funding. Latest round: Seed.
Haisheng Zhang is the Co-Founder and President of Signet Therapeutics, a clinical-stage biotech company developing targeted cancer therapies. He also holds a position as a Research Fellow at Dana-Farber Cancer Institute and is Co-President at MIT-CHIEF. Zhang founded Signet Therapeutics in 2020, focusing on first-in-class oncology treatments.
Full founder directory · Investor directory · Company funding database · Fundraising library